Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 789

1.

Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?

Banz-Jansen C, Heinrichs A, Hedderich M, Waldmann A, Wedel B, Mebes I, Diedrich K, Rody A, Fischer D.

Arch Gynecol Obstet. 2013 Aug;288(2):379-83. doi: 10.1007/s00404-013-2738-7. Epub 2013 Feb 14.

PMID:
23407999
2.

Characteristics and therapy of premenopausal patients with early-onset breast cancer in Germany.

Banz-Jansen C, Heinrichs A, Hedderich M, Waldmann A, Dittmer C, Wedel B, Mebes I, Diedrich K, Fischer D.

Arch Gynecol Obstet. 2012 Aug;286(2):489-93. doi: 10.1007/s00404-012-2291-9. Epub 2012 Apr 11.

PMID:
22491806
3.

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.

Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Chinese.

PMID:
21029696
4.

[Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].

Modesto A, Gandy C, Mery E, Filleron T, Massabeau C, Izar F, Charitansky H, Roché H, de Lafontan B.

Cancer Radiother. 2014 Mar;18(2):107-10. doi: 10.1016/j.canrad.2013.12.007. Epub 2014 Mar 14. French.

PMID:
24637020
5.

Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.

Milgrom S, Cody H, Tan L, Morrow M, Pesce C, Setton J, Rogers K, Arnold B, Eaton A, Catalano J, McCormick B, Powell S, Ho A.

Ann Surg Oncol. 2012 Nov;19(12):3762-70. doi: 10.1245/s10434-012-2386-3. Epub 2012 May 11.

PMID:
22576064
6.

[Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].

Ma WY, Zhang P, Zhang BL, Wang X, Xu XZ, Zheng S, Wang JY, Cai RG, Yuan P, Ma F, Fan Y, Xu BH.

Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):770-4. doi: 10.3760/cma.j.issn.0253-3766.2012.10.011. Chinese.

PMID:
23291072
7.

Rare breast cancer: 933 adenoid cystic carcinomas from the National Cancer Data Base.

Kulkarni N, Pezzi CM, Greif JM, Suzanne Klimberg V, Bailey L, Korourian S, Zuraek M.

Ann Surg Oncol. 2013 Jul;20(7):2236-41. doi: 10.1245/s10434-013-2911-z. Epub 2013 Mar 1.

PMID:
23456318
8.

Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.

Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM.

Ann Surg Oncol. 2012 Sep;19(9):3019-27. doi: 10.1245/s10434-012-2322-6. Epub 2012 Mar 27.

PMID:
22451233
9.

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.

Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, Lebeau A, Liedtke C, von Minckwitz G, Nekljudova V, Schmatloch S, Schrenk P, Staebler A, Untch M.

Lancet Oncol. 2013 Jun;14(7):609-18. doi: 10.1016/S1470-2045(13)70166-9. Epub 2013 May 15.

PMID:
23683750
10.

Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.

Kapoor NS, Shamonki J, Sim MS, Chung CT, Giuliano AE.

Ann Surg Oncol. 2013 Aug;20(8):2576-81. doi: 10.1245/s10434-013-2924-7. Epub 2013 Mar 7.

PMID:
23468047
11.

The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy.

Straver ME, Rutgers EJ, Rodenhuis S, Linn SC, Loo CE, Wesseling J, Russell NS, Oldenburg HS, Antonini N, Vrancken Peeters MT.

Ann Surg Oncol. 2010 Sep;17(9):2411-8. doi: 10.1245/s10434-010-1008-1. Epub 2010 Apr 6.

12.

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15.

PMID:
10421533
13.

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, Gerber B, Eiermann W, Hilfrich J, Huober J, Jackisch C, Kaufmann M, Konecny GE, Denkert C, Nekljudova V, Mehta K, Loibl S.

J Clin Oncol. 2012 May 20;30(15):1796-804. doi: 10.1200/JCO.2011.38.8595. Epub 2012 Apr 16.

PMID:
22508812
14.

Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.

Rais G, Raissouni S, Aitelhaj M, Rais F, Naciri S, Khoyaali S, Abahssain H, Bensouda Y, Khannoussi B, Mrabti H, Errihani H.

BMC Womens Health. 2012 Oct 7;12:35. doi: 10.1186/1472-6874-12-35.

15.

Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy.

Schneider J, Gonzalez-Roces S, Pollán M, Lucas R, Tejerina A, Martin M, Alba A.

Breast Cancer Res. 2001;3(3):183-91. Epub 2001 Feb 1.

16.

Predicting axillary sentinel node status in patients with primary breast cancer.

Kolarik D, Pecha V, Skovajsova M, Zahumensky J, Trnkova M, Petruzelka L, Halaska M, Sottner O, Otcenasek M, Kolarova H.

Neoplasma. 2013;60(3):334-42. doi: 10.4149/neo_2013_045.

PMID:
23374005
17.

[Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].

Li Q, Xu BH, Zhang P, Li Q, Yuan P, Wang JY, Luo Y, Ma F, Fan Y, Li Q.

Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):207-11. doi: 10.3760/cma.j.issn.0253-3766.2013.03.010. Chinese.

PMID:
23880002
18.

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ; Panel Members.

Ann Oncol. 2015 Aug;26(8):1533-46. doi: 10.1093/annonc/mdv221. Epub 2015 May 4.

19.

Breast cancer in very young women.

Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J.

Eur J Surg Oncol. 2011 Dec;37(12):1030-7. doi: 10.1016/j.ejso.2011.08.133. Epub 2011 Sep 21.

PMID:
21937191
20.

Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?

Sanuki N, Takeda A, Amemiya A, Ofuchi T, Ono M, Ogata H, Yamagami R, Hatayama J, Eriguchi T, Kunieda E.

Clin Breast Cancer. 2013 Feb;13(1):69-76. doi: 10.1016/j.clbc.2012.09.005. Epub 2012 Oct 11.

PMID:
23062706

Supplemental Content

Support Center